← Evidence map

ReviewTherapeutics and clinical risk management2014

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation.

Alexander Gg TurpiePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2014
2015
2016
2017
2018
2019
2020
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 24711702